Viewing Study NCT06621680



Ignite Creation Date: 2024-10-26 @ 3:41 PM
Last Modification Date: 2024-10-26 @ 3:41 PM
Study NCT ID: NCT06621680
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-09-29

Brief Title: Effect of Connective Tissue Massage on Premenstrual Syndrome
Sponsor: None
Organization: None

Study Overview

Official Title: Effect of Connective Tissue Massage on Premenstrual Syndrome
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study will be conducted to investigate the effect of connective tissue massage on premenstrual syndrome
Detailed Description: Premenstrual syndrome is a collection of emotional physiological and behavioral symptoms that develop around the end of the luteal phase and fade away with or after mensturation

The physiological effects of connective tissue massage CTM are both local and general Local effects include release of histamine from mast cells which leads to a triple response local swelling and arteriolar dilatation mediated by local axon reflexes The increased blood flow to the region assists resolution of subacute or chronic inflammation and reduces pain by removing nocigenic chemicals from the tissues The mechanical distortions produced by CTM strokes help to mobilize connective tissue and improve function

Few studies have investigated the effect of the CTM on premenstrual syndrome in adolescent females So this study will be conducted to add new information about the effect of connective tissue massage on premenstrual syndrome which may help adolescent females suffering from this syndrome in decreasing their symptoms thus adding new information to the field of physical therapy

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None